Patents by Inventor Raili Kerppola

Raili Kerppola has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
    Publication number: 20220160662
    Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
    Type: Application
    Filed: June 30, 2021
    Publication date: May 26, 2022
    Inventors: Gary Hammer, Tom Kerppola, Raili Kerppola
  • COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
    Publication number: 20180256524
    Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
    Type: Application
    Filed: December 12, 2017
    Publication date: September 13, 2018
    Inventors: Gary Hammer, Tom Kerppola, Raili Kerppola
  • Compounds and methods for treating aberrant adrenocortical cell disorders
    Patent number: 9877937
    Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethyl amino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: January 30, 2018
    Assignees: The Regents of the Univeristy of Michigan, Millendo Therapeutics, Inc.
    Inventors: Gary Hammer, Tom Kerppola, Raili Kerppola
  • COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
    Publication number: 20160367507
    Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethyl amino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
    Type: Application
    Filed: June 1, 2016
    Publication date: December 22, 2016
    Inventors: Gary Hammer, Tom Kerppola, Raili Kerppola
  • Compounds and methods for treating aberrant adrenocortical cell disorders
    Patent number: 9446010
    Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: September 20, 2016
    Assignees: The Regents of the University of Michigan, Millendo Therapeutics, Inc.
    Inventors: Gary Hammer, Tom Kerppola, Raili Kerppola
  • COMPOUNDS AND METHODS FOR TREATING ABERRANT ADRENOCORTICAL CELL DISORDERS
    Publication number: 20160008302
    Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 14, 2016
    Inventors: Gary Hammer, Tom Kerppola, Raili Kerppola
  • Compounds and methods for treating aberrant adrenocartical cell disorders
    Patent number: 9107883
    Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: August 18, 2015
    Assignees: Atterocor, Inc., The Regents of the University of Michigan
    Inventors: Gary Hammer, Tom Kerppola, Raili Kerppola
  • Compounds and Methods for Treating Aberrant Adrenocartical Cell Disorders
    Publication number: 20130267550
    Abstract: Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N?-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 10, 2013
    Inventors: Gary Hammer, Tom Kerppola, Raili Kerppola
  • COMPOSITIONS AND METHODS FOR TREATING, CONTROLLING, REDUCING, OR AMELIORATING INFECTIONS AND SEQUELAE THEREOF
    Publication number: 20080033008
    Abstract: A composition for treating, controlling, reducing, ameliorating, or alleviating infections and their inflammatory sequelae comprises a dissociated glucocorticoid receptor agonist (“DIGRA”) and an anti-infective agent, such as an antibacterial, antiviral, antifungal, antiprotozoal agent, or a combination thereof. The composition can be formulated for topical application, injection, or implantation.
    Type: Application
    Filed: August 1, 2007
    Publication date: February 7, 2008
    Inventors: Keith W. Ward, Zhenze Hu, Gary Phillips, Raili Kerppola
  • COMPOSITIONS AND METHODS FOR TREATING, REDUCING, AMELIORATING, OR ALLEVIATING POSTERIOR-SEGMENT OPHTHALMIC DISEASES
    Publication number: 20080031884
    Abstract: A composition for treating, reducing, ameliorating, or alleviating a back-of-the-eye condition or disorder that has an etiology in inflammation comprises a dissociated glucocorticoid receptor agonist (“DIGRA”). The compositions also can include other anti-inflamatory agents, anti-angiogenic agents, or combinations thereof. The composition can be formulated for topical application, injection, or implantation. The composition can be administered alone or in combination with another procedure chosen to enhance the outcome of the treatment.
    Type: Application
    Filed: August 1, 2007
    Publication date: February 7, 2008
    Inventors: Keith W. Ward, Zhenze Hu, Gary Phillips, Raili Kerppola